Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

Marta del Campo, Brit Mollenhauer, Antonio Bertolotto, Sebastiaan Engelborghs, Harald Hampel, Anja Hviid Simonsen, Elisabeth Kapaki, Niels Kruse, Nathalie Le Bastard, Sylvain Lehmann, Jose Luis Molinuevo, Lucilla Parnetti, Armand Perret-Liaudet, Javier Saez-Valero, Esen Saka, Andrea Urbani, Eugeen Vanmechelen, Marcel M. Verbeek, Pieter Jelle Visser, Charlotte Teunissen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)419-430
JournalBiomarkers in Medicine
Volume6
Issue number4
DOIs
Publication statusPublished - Aug 2012

Keywords

  • Alzheimer's disease
  • biomarkers
  • CSF
  • early diagnosis
  • guidelines
  • Parkinson's disease
  • preanalytical factors
  • recommendations
  • standard operating procedures

Cite this

del Campo, M., Mollenhauer, B., Bertolotto, A., Engelborghs, S., Hampel, H., Simonsen, A. H., Kapaki, E., Kruse, N., Le Bastard, N., Lehmann, S., Molinuevo, J. L., Parnetti, L., Perret-Liaudet, A., Saez-Valero, J., Saka, E., Urbani, A., Vanmechelen, E., Verbeek, M. M., Visser, P. J., & Teunissen, C. (2012). Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update. Biomarkers in Medicine, 6(4), 419-430. https://doi.org/10.2217/BMM.12.46